Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · September 03, 2023

Association Between Posaconazole and the Risk of Cutaneous Squamous Cell Carcinoma After Lung Transplantation

Archives of Dermatological Research

 

Additional Info

Archives of Dermatological Research
Posaconazole and risk of cutaneous squamous cell carcinoma after lung transplantation: a single institution, retrospective cohort study
Arch Dermatol Res 2023 Aug 09;[EPub Ahead of Print], LF Kuklinski, AM Klomhaus, A Shen, N Achamallah, TT Soriano, R Saggar, SS Weigt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading